Marketing and Licensing Agreements

Raydiance and Food and Drug Administration Sign Cooperative Research and Development Agreement

Published in Health Business Week, August 3rd, 2007

Raydiance, Inc., developer of the world's first compact, cost-effective and fully software-controlled UltraShort Pulse (USP) laser system, announced that it has entered into a two-year cooperative research and development agreement (CRADA) with the U.S. Food and Drug Administration (FDA).

Under the agreement, the FDA will utilize Raydiance's USP laser platform to evaluate the safety and effectiveness of high power laser-tissue interaction. The collaboration will involve the FDA's Division of Physics, Office of Science and Engineering Laboratories; Center for Devices and Radiological Health (CDRH), with hardware, software, applications and research support provided by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-08-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry